Title : Molecular markers in acute myeloid leukaemia.

Pub. Date : 2012 Aug

PMID : 22791509






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Moreover, the characterisation of specific molecular abnormalities provides the basis for targeted therapies, such as all trans retinoic acid (ATRA) and arsenic trioxide treatment in acute promyelocytic leukaemia or tyrosine kinase inhibitors in AML with FLT3 mutations. Arsenic Trioxide fms related receptor tyrosine kinase 3 Homo sapiens